Soluble urokinase plasminogen activator receptor and interleukin-6 improves prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes. [PDF]
Bahrami HSZ +7 more
europepmc +1 more source
Association of plasma soluble urokinase plasminogen activator receptor concentrations and migraine with aura: a REFORM study. [PDF]
Tesfay B +8 more
europepmc +1 more source
Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study. [PDF]
Yadalam AK +5 more
europepmc +1 more source
Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients. [PDF]
Wozniak P +5 more
europepmc +1 more source
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Plasma Concentration Is Reduced Using Minimized Extracorporeal Circulation: Results of a Secondary Analysis of a Prospective Observational Study. [PDF]
Zajonz TS +6 more
europepmc +1 more source
Soluble Urokinase Plasminogen Activator Receptor: A Useful Marker for Predicting Mortality in COVID-19 Patients. [PDF]
Sehgal T +3 more
europepmc +1 more source
The dynamic role of soluble urokinase plasminogen activator receptor (suPAR) in monitoring coagulation dysfunction during COVID-19 progression: a review. [PDF]
Obeagu EI.
europepmc +1 more source
Establishing reference intervals for soluble urokinase plasminogen activator receptor in Northern European adults. [PDF]
Bruun SB, Madsen JB, Brasen CL.
europepmc +1 more source
The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock. [PDF]
Turan C +4 more
europepmc +1 more source

